POMALYST
Natco Pharma's marketing partner gets USFDA nod for cancer treatment drug"Breckenridge Pharmaceutical Inc. has received final approval for its abbreviated new drug application (ANDA) for Pomalidomide Capsules fro...13 Nov, 2020, 12.01 PM IST
Buy Aurobindo Pharma, target Rs 920: Phillip Capital (India)Buy Aurobindo Pharma at a price target of Rs 920.21 Jan, 2019, 05.51 PM IST
Natco Pharma launches generic blood cancer drug in IndiaNatco has launched pomalidomide capsules in strengths of 1 mg, 2 mg and 4 mg in India.10 May, 2017, 11.07 AM IST
Load More